Insights

Innovative Technology Adoption Acclarent has demonstrated a strong commitment to advancing ENT surgical solutions through the launch of AI-powered navigation systems and balloon dilation technologies, indicating a readiness to invest in cutting-edge minimally invasive procedures that improve patient outcomes.

Growing Market Presence With over 535,000 balloon sinuplasty procedures globally, Acclarent's established and expanding procedure volumes suggest significant market penetration and potential for increased sales of related accessories, upgrades, and complementary technology solutions.

Strategic Acquisition Backing Being part of Integra LifeSciences since 2017 provides Acclarent with enhanced financial stability and resources, creating opportunities for sales partnerships, joint innovation projects, and expanded product offerings in the ENT sector.

Focus on ENT Innovation Acclarent's dedicated focus on ENT-specific minimally invasive devices and AI-enabled surgical tools positions it as a key partner for healthcare providers seeking to adopt advanced surgical workflows, opening avenues for upselling and customized device solutions.

Medium Revenue Scope With revenues between $50 million and $100 million and a relatively lean workforce, Acclarent offers targeted sales opportunities to vascularize new product integrations, service upgrades, and expand within niche ENT markets through tailored outreach strategies.

Acclarent Tech Stack

Acclarent uses 6 technology products and services including Drupal, jQuery, PHP, and more. Explore Acclarent's tech stack below.

  • Drupal
    Content Management System
  • jQuery
    Javascript Libraries
  • PHP
    Programming Languages
  • Google Analytics
    Web Analytics
  • Adobe Fonts
    Web Fonts
  • prettyPhoto
    Web Tools And Plugins

Media & News

Acclarent's Email Address Formats

Acclarent uses at least 1 format(s):
Acclarent Email FormatsExamplePercentage
FLast@acclarent.comJDoe@acclarent.com
64%
First.Last@acclarent.comJohn.Doe@acclarent.com
24%
FirstLast@acclarent.comJohnDoe@acclarent.com
6%
Last.First@acclarent.comDoe.John@acclarent.com
6%

Frequently Asked Questions

What is Acclarent's phone number?

Minus sign iconPlus sign icon
You can contact Acclarent's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Acclarent's official website and social media links?

Minus sign iconPlus sign icon
Acclarent's official website is acclarent.com and has social profiles on LinkedIn.

What is Acclarent's NAICS code?

Minus sign iconPlus sign icon
Acclarent's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Acclarent have currently?

Minus sign iconPlus sign icon
As of December 2025, Acclarent has approximately 223 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Chief Financial Officer & Finanical Advisor: M. K.€�chief Executive & President: R. B.Vice President, Human Resources: A. H.. Explore Acclarent's employee directory with LeadIQ.

What industry does Acclarent belong to?

Minus sign iconPlus sign icon
Acclarent operates in the Medical Equipment Manufacturing industry.

What technology does Acclarent use?

Minus sign iconPlus sign icon
Acclarent's tech stack includes DrupaljQueryPHPGoogle AnalyticsAdobe FontsprettyPhoto.

What is Acclarent's email format?

Minus sign iconPlus sign icon
Acclarent's email format typically follows the pattern of FLast@acclarent.com. Find more Acclarent email formats with LeadIQ.

How much funding has Acclarent raised to date?

Minus sign iconPlus sign icon
As of December 2025, Acclarent has raised $26M in funding. The last funding round occurred on Jan 12, 2009 for $26M.

Acclarent

Medical Equipment ManufacturingCalifornia, United States201-500 Employees

Acclarent, Inc., part of Integra LifeSciences, is a medical device company in Irvine, CA that was established in June of 2004. We’re dedicated to supporting Ear, Nose, and Throat (ENT) surgeons with minimally invasive technologies designed to preserve nasal anatomy, while addressing rhinosinusitis and persistent Eustachian Tube Dysfunction. 

Commercially launched in 2005, our Balloon Sinuplasty technology has been used by otolaryngologists in over 535,000 procedures.

©Acclarent,  Inc. 2022

Section iconCompany Overview

Phone number
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Employees
201-500

Section iconFunding & Financials

  • $26M

    Acclarent has raised a total of $26M of funding over 4 rounds. Their latest funding round was raised on Jan 12, 2009 in the amount of $26M.

  • $50M$100M

    Acclarent's revenue is estimated to be in the range of $50M$100M

Section iconFunding & Financials

  • $26M

    Acclarent has raised a total of $26M of funding over 4 rounds. Their latest funding round was raised on Jan 12, 2009 in the amount of $26M.

  • $50M$100M

    Acclarent's revenue is estimated to be in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.